Joe Lennerz
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Joe Lennerz
Jul 17, 2024, 23:35 |
Blog
Joe Lennerz: The role of FGFR alterations in thyroid carcinoma
Joe Lennerz, Chief Scientific Officer at BostonGene, on LinkedIn: "FGFR fusions in thyroid cancer are important…
May 17, 2024, 16:25 |
Blog
Joe Lennerz: Cover Story in Cancer Cell
Joe Lennerz, Chief Scientific Officer at BostonGene, shared on LinkedIn: "Cover Story in Cancer Cell.…
Apr 15, 2024, 21:31 |
Blog
Uta Schmidt-Straßburger: Pathology innovation is not an oxymoron – it is rather magic
Uta Schmidt-Straßburger, Scientific Director at Ulm University, shared a post by Advanced Oncology on LinkedIn:…
Apr 13, 2024, 12:47 |
Societies
Advanced Oncology's podcast guest is non other than the Chief Scientific Officer of BostonGene Dr. Joe Lennerz
Advanced Oncology posted on Instagram: "Please look forward to our new podcast episode this Friday!…
Apr 12, 2024, 05:34 |
Insight
Joe Lennerz: Quickly sharing a fantastic paper on tumour infiltrating lymphocytes in triple-negative breast cancer
Joe Lennerz, Chief Scientific Officer at BostonGene, shared on LinkedIn: "Quickly sharing a fantastic paper…
Dec 12, 2023, 18:08 |
Career
Joe Lennerz was appointed as the Chief Scientific Officer at BostonGene
Quoting Joe Lennerz, Chief Scientific Officer at BostonGene, on LinkedIn: ''Some brief personal news. I've…
All:
6
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube